ICAD - ICAD INC
IEX Last Trade
1.82
-0.120 -6.593%
Share volume: 0
Last Updated: Tue 24 Dec 2024 06:07:18 PM CET
Data Processing, Hosting, and Related Services:
31.52%
PREVIOUS CLOSE
CHG
CHG%
$1.94
-0.12
-6.19%
Fundamental analysis
5%
Profitability
0%
Dept financing
21%
Liquidity
31%
Performance
0%
Performance
5 Days
-2.73%
1 Month
12.66%
3 Months
14.84%
6 Months
37.98%
1 Year
4.71%
2 Year
0 0%
Key data
Stock price
$1.82
DAY RANGE
$1.72 - $1.94
52 WEEK RANGE
$1.23 - $2.65
52 WEEK CHANGE
-$5.32
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/13/2024
Company detail
CEO: Stacey M. Stevens
Region: US
Website: icadmed.com
Employees: 140
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Data Processing, Hosting, and Related Services
Sector: Information
Region: US
Website: icadmed.com
Employees: 140
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Data Processing, Hosting, and Related Services
Sector: Information
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers.
Recent news